振东制药：累计回购公司股份13016700股

Summary of Key Points Core Viewpoint - Zhendong Pharmaceutical announced a share buyback plan, indicating a strategic move to enhance shareholder value and confidence in the company's future prospects [1] Group 1: Share Buyback Details - As of August 31, 2025, the company has repurchased a total of 13,016,700 shares, which represents 1.29% of the current total share capital [1] - The maximum purchase price for the shares was RMB 10.06 per share, while the minimum purchase price was RMB 3.51 per share [1] - The total amount spent on the share buyback reached RMB 52,030,929, excluding transaction fees [1]